Real-world outcomes of pemetrexed-platinum chemotherapy plus osimertinib after progression on first-line osimertinib in advanced EGFR-mutated NSCLC
-
Published:2024-07
Issue:
Volume:193
Page:107856
-
ISSN:0169-5002
-
Container-title:Lung Cancer
-
language:en
-
Short-container-title:Lung Cancer
Author:
Saw Stephanie P.L.ORCID,
Low Yi Fen,
Lai Gillianne G.Y.ORCID,
Chan Landon L.,
Wong Wesley K.Y.,
Tsui GiselleORCID,
Chen Olivia H.,
Seet Amanda O.L.,
Tan Wei Chong,
Tan Aaron C.,
Chan Johan W.K.,
Teh Yi Lin,
Tan Wan-Ling,
Ng Quan Sing,
Ang Mei-KimORCID,
Kanesvaran Ravindran,
Lim Darren W.T.ORCID,
Tan Daniel S.W.,
Mok Tony S.K.,
Li Molly S.C.ORCID